Voelker M T, Jahn N, Bercker S, Becker-Rux D, Köppen S, Kaisers U X, Laudi S
Klinik und Poliklinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Leipzig, Liebigstr. 20, 04107, Leipzig, Deutschland.
Anaesthesist. 2016 Apr;65(4):250-7. doi: 10.1007/s00101-015-0131-6. Epub 2016 Mar 23.
Prone positioning of patients with acute respiratory distress syndrome (ARDS) has been shown to significantly improve survival rates. Prone positioning reduces collapse of dorsal lung segments with subsequent reduction of alveolar overdistension of ventral lung segments, optimizes lung recruitment and enhances drainage. Patients with ARDS treated by extracorporeal membrane oxygenation (ECMO) can also benefit from prone positioning; however, the procedure is associated with a possible higher risk of serious adverse events.
The aim of this study was to evaluate the safety and feasibility of prone positioning for patients with severe ARDS during ECMO therapy.
This study involved a retrospective analysis of all patients placed in a prone position while being treated by venovenous ECMO (vvECMO) for severe hypoxemia in ARDS as bridge to recovery in the interdisciplinary intensive care unit at the University Hospital Leipzig between January 2009 and August 2013. Baseline data, hospital mortality and serious adverse events were documented. Serious adverse events were defined as dislocation or obstruction of endotracheal tube or tracheal cannula, ECMO cannulas and cardiac arrest. Prone positioning was carried out by at least one doctor and three nurses according to a standardized protocol. Results are given as the median (1st and 3rd quartiles).
A total of 26 patients were treated with vvECMO as bridge to recovery due to severe ARDS. Causes for ARDS were pneumonia (n = 20) and aspiration (n = 2) and four patients had different rare causes of ARDS. The median time on ECMO was 8 days (6;11) and during this period 134 turning events were documented. Patients were proned for a median of 5 (3;7) periods with a median duration of 12 h (8;12). No serious adverse events were recorded. The hospital mortality was 42% and mortality during the ECMO procedure was 35%.
Prone positioning significantly reduces the mortality of patients with severe ARDS. In this series of 26 patients with severe ARDS during ECMO therapy no serious adverse events were found during the use of prone positioning.
急性呼吸窘迫综合征(ARDS)患者采用俯卧位已被证明可显著提高生存率。俯卧位可减少背侧肺段萎陷,进而减少腹侧肺段的肺泡过度扩张,优化肺复张并促进引流。接受体外膜肺氧合(ECMO)治疗的ARDS患者也可从俯卧位中获益;然而,该操作可能会带来更高的严重不良事件风险。
本研究旨在评估在ECMO治疗期间,俯卧位用于重度ARDS患者的安全性和可行性。
本研究对2009年1月至2013年8月期间在莱比锡大学医院跨学科重症监护病房接受静脉-静脉ECMO(vvECMO)治疗严重低氧血症性ARDS以过渡到康复阶段的所有俯卧位患者进行了回顾性分析。记录基线数据、医院死亡率和严重不良事件。严重不良事件定义为气管内导管或气管套管移位或阻塞、ECMO套管和心脏骤停。俯卧位由至少一名医生和三名护士按照标准化方案进行。结果以中位数(第1和第3四分位数)表示。
共有26例患者因重度ARDS接受vvECMO治疗以过渡到康复阶段。ARDS的病因包括肺炎(n = 20)和误吸(n = 2),另有4例患者有不同的罕见ARDS病因。ECMO的中位时间为8天(6;11),在此期间记录了134次翻身事件。患者俯卧的中位次数为5次(3;7),中位持续时间为12小时(8;12)。未记录到严重不良事件。医院死亡率为42%,ECMO治疗期间的死亡率为35%。
俯卧位可显著降低重度ARDS患者的死亡率。在这组26例接受ECMO治疗的重度ARDS患者中,使用俯卧位期间未发现严重不良事件。